Connection

Co-Authors

Back to Details
This is a "connection" page, showing publications co-authored by Robert Chen and Marc Gurwith.
Robert Chen
Connection Strength
0.565
Marc Gurwith
  1. Brighton Collaboration Viral Vector Vaccines Safety Working Group (V3SWG) standardized template for collection of key information for benefit-risk assessment of live-attenuated viral vaccines. Vaccine. 2020 11 17; 38(49):7702-7707.
    View in: PubMed
    Score: 0.227
  2. The critical role of background rates of possible adverse events in the assessment of COVID-19 vaccine safety. Vaccine. 2021 05 06; 39(19):2712-2718.
    View in: PubMed
    Score: 0.058
  3. Vaccines based on replication incompetent Ad26 viral vectors: Standardized template with key considerations for a risk/benefit assessment. Vaccine. 2021 05 21; 39(22):3081-3101.
    View in: PubMed
    Score: 0.057
  4. The Brighton Collaboration standardized template for collection of key information for benefit-risk assessment of viral vector vaccines. Vaccine. 2020 11 17; 38(49):7708-7715.
    View in: PubMed
    Score: 0.056
  5. The Brighton Collaboration standardized template for collection of key information for benefit-risk assessment of inactivated viral vaccines. Vaccine. 2020 09 03; 38(39):6184-6189.
    View in: PubMed
    Score: 0.056
  6. The Brighton Collaboration standardized template for collection of key information for benefit-risk assessment of protein vaccines. Vaccine. 2020 07 31; 38(35):5734-5739.
    View in: PubMed
    Score: 0.056
  7. The Brighton Collaboration standardized template for collection of key information for benefit-risk assessment of nucleic acid (RNA and DNA) vaccines. Vaccine. 2020 07 22; 38(34):5556-5561.
    View in: PubMed
    Score: 0.055
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.